DRDO releases 1st batch of anti-covid drug 2-DG Yes, this news is correct. Today union defence minister of India launched anti-covid drug 2-deoxy-D-glucose (2-DG) developed by Defence Research and Development Organisation (DRDO). I have watched the program on TV news channel. Study shows that 2-DG medicine is capable to decrease recovery time and oxygen dependency. How will 2-DG work against covid-19? 2-DG molecule drug was actually being developed for treating tumour, cancer cells. When covid 19 attacked the country, scientists started testing this glucose analogue in covid patients. This medicine is nothing but a glucose analogue, but actually it is not a glucose. When 2-DG will be administered in the human body, the virus will consume it. A virus needs energy to multiply cells fast in the body. As the virus will take this glucose analogue, they will stop multiplying their cells. And the recovery process will be fast. You can read the news here https://www.hindustantimes.com/india-news/drdos-1st-batch-of-anti-covid-drug-2dg-launched-101621228944110.html [The image is taken from hindustantimes.com] #News